Our Commitment to Pharmaceutical Innovation

Bio-Europe 2025 serves as a leading platform for partnering, business development, and networking in the biopharmaceutical and life sciences industries. As a trusted CDMO, Actelion Pharmaceuticals Deutschland GmbH remains dedicated to delivering:

Comprehensive CDMO solutions for pharmaceutical development and manufacturing
Innovative approaches to supply chain and operational excellence
Collaborative opportunities to accelerate market entry and expansion
A strong commitment to quality, sustainability, and regulatory compliance

Meet our Key Speaker

Marie-Sophie Quittet
Head of Strategic Projects, Jura

Marie-Sophie holds both a Doctor of Pharmacy (PharmD) and a Doctor of Philosophy (PhD), showcasing her expertise in the pharmaceutical industry. As Head of Strategic Projects, she has over a decade of experience, spearheading clinical production projects in Europe and the US.

Meet our Key Speaker

Nancy Martinez

Senior Business Development Manager

With a strong scientific background in biologics, CDMO services, and clinical project management. Currently at Actelion Pharmaceuticals Deutschland GmbH Jura, she previously held key roles at GTP Bioways and Pierre Fabre, supporting innovative biotech and pharma projects across Europe. With expertise ranging from antibody development and aseptic Fill & Finish to client relationship management and strategic sales, Nancy brings a unique mix of technical insight and commercial acumen to the life sciences industry.

Connect with Us in Vienna

Our team will be attending Bio-Europe 2025, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.

November 3–5, 2025
Vienna, Austria

We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.

Explore Our Key Services

At CPHI, we would love to have you come stop by our booth and talk to our experts about our CDMO offerings!

Drug Development

We provide customised CDMO services designed to meet the diverse needs of the industry. From out-licensing and supply to one-off analysis, custom developments, and advanced formulation services.

⟶

Commercial Manufacturing

Our CDMO manufacturing network includes four state-of-the-art facilities in Europe and one in Japan, each staffed with a dedicated team committed to delivering unparalleled quality in every offering and solution we provide.

⟶

Clinical Manufacturing

We guide your project through every phase of clinical manufacturing, from feasibility studies and preclinical material preparation to GMP-compliant production. Our end-to-end approach ensures seamless transitions between phases, delivering high-quality solutions tailored to your clinical needs. 

⟶

Our Services

We offer fully integrated CDMO services covering the entire process: from initial planning and supply chain management to regulatory affairs, for your drug product.

⟶

Mark Your Calendars – Exciting Things Are Coming!

Run With actelion!

This year we will be hosting a run during our participation at CPHI! Whether you prefer to sprint, jog or take a leisurely walk, everyone is welcome to join us. It is the perfect opportunity to stretch your legs before a busy day.
Register below for more details.

 Date: 29th October 2025 at 8:30 am
Location: Grüneburg park, Frankfurt, Germany

Do you want to participate?

A Full-Theme German Evening!

This is a private event where you can enjoy an apple wine tasting, a delectable appetizer tour, and a classic German dinner for an authentic culinary experience!

Would you like to participate?
Visit us at our booth at CPHI and ask for more information!

About Last Year CPHI In Milan

Meet Our Team Of Experts

At CPHI you will have the opportunity to talk directly to our team of experts, including our CEO.

Dr. Andreas Raabe

CEO

Henny Zijlstra

CCO

Marco Gorgas

COO

Christina Yfanti

Business Development Manager, Athens

Gael Le Saux

Site Head, Livron

Gorka Martinez

Business Development Manager, Barcelona

Nicole Fité

Business Development Manager, Barcelona

Juan Gonzalez

Business Development Manager, Barcelona

Munetaka Hirosaki

Customer Relationship Manager, Kawagoe

Florian Prell

Site Head, Leipzig

Aggelos Karatzas

Site Head, Athens

Mike Stradling

Managing Director, Jura

Interphex Week Special Lecture 2
 Date: Thursday, July 10, 2025｜15:00 ～16:00
Location: Big Sight Tokyo, Japan [Venue A East Hall]

About The Event

​Interphex Tokyo is approaching, and we are excited to announce a special seminar hosted by our Chief Commercial Officer, Henny Zijlstra, and Head of US & APAC, Hideyuki Tanaka.

The seminar will explore the unique challenges women encounter in both Japan and Western countries in the pharmaceutical industry, highlight the critical importance of supporting female leadership in pharma, and share personal hopes and visions for the future of women’s empowerment.

Why You Should Attend

This event is the perfect fit for you if you are interested in hearing a discussion form different perpectives about how we can all do our part in empowering women and why women empowerment is crucial in our industry!

Whether you are a experienced leader or just starting your career in the industry we are inviting you to join this seminar!

Our Key Speakers

We are honored to welcome our expert speakers, Henny Zijlstra and Hideyuki Tanaka from Actelion Pharmaceuticals Deutschland GmbH, who will share their insights and experiences on empowering women, promoting diversity, and driving innovation in the pharmaceutical industry at our “Women in Pharma” event in Tokyo.

Henny Zijlstra, Chief Commercial Officer (CCO)

Meet Henny, our esteemed Chief Commercial Officer (CCO) at Actelion Pharmaceuticals Deutschland GmbH. Henny leads with a customer-first approach, driving our mission to deliver superior experiences and outcomes. With extensive experience in the pharmaceutical CDMO industry, she disrupts the market with innovative strategies that fuel progress and innovation. Passionate about promoting diversity and inclusion, Henny actively serves as a role model for the next generation of female leaders. Her leadership raises the bar, inspiring our team to exceed expectations while fostering deep connections with customers.

Hideyuki Tanaka, Head of Commercial US & APAC

Hide serves as actelion’ Head Commercial US & APAC and brings over two decades of experience within the pharmaceutical and CDMO industry. He has an extensive global background spanning the United States, Europe, and Japan. Throughout Hide’s career, he has excelled in roles covering sales, marketing, business development, corporate governance, project management, and medicinal chemistry.  Possessing a Master’s in Pharmaceutical Chemistry and an MBA from Bond University in Australia, Hide exemplifies an unwavering commitment to professional growth.

Date: July 9-11, 2025
Location: Big Sight, Tokyo, Japan
Booth Number: #W2-40

Our Commitment to Pharmaceutical Innovation

Interphex is a premier event for showcasing innovation, technology, and collaboration in the pharmaceutical and bioprocessing sectors. Actelion Pharmaceuticals Deutschland GmbH will take part to this event, where a team of local experts offer deep regulatory knowledge, technical expertise, and experience tailored to both Japanese and non-Japanese pharmaceutical companies.

We are committed to:

Providing seamless CDMO solutions for pharmaceutical development, manufacturing, and packaging that meet Japanese quality and regulatory standards
Guiding non-Japanese companies through every step of Japanese market entry—from registration to commercialization
Supporting Japanese companies with innovative strategies for operational excellence and supply chain optimization
Ensuring a smooth, compliant, and efficient path to success in Japan’s dynamic pharmaceutical landscape

Visit us at INTERPHEX to discover how our Kawagoe facility and expert team can help you navigate and thrive in the Japanese market.

Meet Our Team at Interphex 2025

We are delighted to share that Henny Zijlstra (Chief Commercial Officer), Masanori Kurogome (Site Head), Hideyuki Tanaka (Head of Commercial US & APAC), and Munetaka Hirosaki (Customer Relationship Manager) will be available for discussions during the event.

Henny Zijlstra, Chief Commercial Officer (CCO)

Henny Zijlstra brings extensive expertise in pharmaceutical manufacturing and business development. She is dedicated to fostering strong client partnerships and driving innovative, customer-centric solutions in the CDMO space.

Masanori Kurogome, Site Head (Kawagoe)

Masanori holds a pharmacy degree with a focus on analytical chemistry. His experience in production broadened his expertise. In 2018, he started programming to expand his skill set. Kurogome is committed to making Actelion Kawagoe an irreplaceable site.

Hideyuki Tanaka, Head of Commercial US & APAC

Hide serves as actelion’ Head Commercial US & APAC and brings over two decades of experience within the pharmaceutical and CDMO industry. He has an extensive global background spanning the United States, Europe, and Japan.

Munetaka Hirosaki, Customer Relationship Manager (Kawagoe)

Munetaka has extensive experience in supply chain management, production, and operational excellence. Previously at Sanofi, he specializes in business development, order management, and strategic customer relations in the pharmaceutical industry.

Connect with Us in Tokyo

Our team will be attending Interphex 2025, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.

July 9-11, 2025
Big Sight, Tokyo, Japan

Booth Number: #W2-40

We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.

Our Business Development Manager, Gorka Martinez, and Head of Strategic Projects, Marie-Sophie Quittet, will represent the company at this premier event.

We invite potential collaborators and customers to connect with us to explore our capacities at our Jura facility, where we specialize in both liquid and lio fill and finish of vials. This is a fantastic opportunity to discuss how we can support your biotech needs.

For more information about the event, visit Swiss Biotech Day. We look forward to meeting you there!

Connect with Us in Basel

Our team will be attending Swiss Biotech Day, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.

May 5 and 6, 2025
Basel, Switzerland

We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.

Our Commitment to Pharmaceutical Innovation

Bio-Europe Spring serves as a leading platform for partnering, business development, and networking in the biopharmaceutical and life sciences industries. As a trusted CDMO, Actelion Pharmaceuticals Deutschland GmbH remains dedicated to delivering:

Comprehensive CDMO solutions for pharmaceutical development and manufacturing
Innovative approaches to supply chain and operational excellence
Collaborative opportunities to accelerate market entry and expansion
A strong commitment to quality, sustainability, and regulatory compliance

Meet our Key Speaker

Juan González

With a strong background in chemistry and pharmaceutical supply chain management, Juan has extensive experience in launch management for finished dosage forms (FDFs), API business development, and cross-functional collaboration with marketing and technical teams. His insights will provide valuable perspectives on supply chain optimization, pharmaceutical partnerships, and industry trends.

Connect with Us in Milan

Our team will be attending Bio-Europe Spring 2025, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.

March 17–19, 2025
Milan, Italy

We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.

Our Commitment to Excellence in CDMO Services

DCAT Week is a key event for the pharmaceutical and biopharmaceutical industries, offering a unique platform for business development and strategic networking. Actelion Pharmaceuticals Deutschland GmbH remains committed to delivering high-quality, cost-effective pharmaceutical manufacturing and development solutions, ensuring operational efficiency and regulatory compliance for our partners worldwide.

Our team will be available to discuss:
Comprehensive CDMO services, including drug development and commercial manufacturing
Innovative solutions for improving supply chain efficiency and production scalability
Opportunities for collaboration to enhance pharmaceutical development and market access
Our dedication to quality, sustainability, and operational excellence

Meet Our Team at DCAT Week 2025

We are delighted to share that Henny Zijlstra, Chief Commercial Officer (CCO), and Dr. Andreas Raabe, Chief Executive Officer (CEO), will be available for discussions during the event.

Dr. Andreas Raabe, Chief Executive Officer (CEO)

Dr. Andreas Raabe is the founder of Actelion Pharmaceuticals Deutschland GmbH, with a strong scientific and strategic background in global pharmaceuticals. His leadership focuses on operational excellence, supply chain optimization, and building a world-class CDMO.

Henny Zijlstra, Chief Commercial Officer (CCO)

Henny Zijlstra brings extensive expertise in pharmaceutical manufacturing and business development. She is dedicated to fostering strong client partnerships and driving innovative, customer-centric solutions in the CDMO space.

Connect with Us in New York

We welcome the opportunity to connect with industry professionals attending DCAT Week 2025. To arrange a meeting, please Corporate Site in advance to schedule a discussion at a convenient time.

March 17–20, 2025
New York City

We look forward to productive discussions and the opportunity to strengthen partnerships that drive innovation in pharmaceutical manufacturing.

Explore Our Key Services 

At CPHI, you will have the opportunity to dive into our key development and manufacturing services by directly talking with our team of experts.

Drug Development

We provide customised CDMO services designed to meet the diverse needs of the industry. From out-licensing and supply to one-off analysis, custom developments, and advanced formulation services.

⟶

Manufacturing Capabilities

Our CDMO manufacturing network includes three state-of-the-art facilities in Europe and one in Japan, each staffed with a dedicated team committed to delivering unparalleled quality in every offering and solution we provide.

⟶

Out-Licensing

As part of our CDMO services, we offer a diverse portfolio of products available for licensing out to our clients worldwide.

⟶

Our CDMO Services

We offer fully integrated CDMO services covering the entire process: from initial planning and supply chain management to regulatory affairs, for your drug product.

⟶

We Have Prepared The Best Events For You!

A Full-Theme Norway Evening!

At our booth, you had the opportunity to try the exclusive Norwegian cocktails!

• Date: Wednesday 9th October 2024
• Location: Fiera Milano
• Booth: #5D74

A Taste Of Italy: Actelion Goes To Milan!

An exclusive Italian Dinner took place in Milan during CPHI 2024.

This private event will bring together industry leaders to enjoy an evening of authentic Italian cuisine paired with a selection of fine wines, beers, and expertly crafted cocktails.

Meet Our Team Of Experts

At CPHI you will have the opportunity to talk directly to our team of experts, including our CEO.

Dr. Andreas Raabe

CEO

Henny Zijlstra

CCO

Marco Gorgas

COO

Aggelos Karatzas

Site Head, Athens

Christina Yfanti

Business Development Manager, Athens

Christina Koulouri

Head of Project Management & Supply Chain, Athens

Argyro Stappa

Head of R&D, Athens

John Kytariolos

Head of Clinical & Scientific Affairs, Athens

Marcus Pursche

Transfer, Leipzig

Gael Le Saux

Site Head, Livron

Nina Gabrielsen

Director Business Development, Halden

Key Trends in Small Molecule Development and Manufacturing

Focus on Rare Diseases

In recent years, the pharmaceutical industry has shifted its focus towards the development of treatments for rare diseases. This trend is driven by incentives such as market exclusivity and reduced regulatory fees. At Actelion Pharmaceuticals Deutschland GmbH, we specialize in small molecule development, crucial for modulating specific molecular targets in rare disease treatments. Our dedicated development site in Athens is equipped to handle both Orphan drug development and Life Cycle Management.

Supply Chain Resilience

The COVID-19 pandemic has underscored the importance of a resilient supply chain. At Actelion Pharmaceuticals Deutschland GmbH, we prioritize the production of raw materials and active pharmaceutical ingredients (APIs) close to our customers in Europe and Japan. This strategic placement ensures continuity and reliability, making us a dependable partner for your pharmaceutical needs.

Sustainability and Green Chemistry

As climate neutrality becomes increasingly vital, the chemical and life science industries are leaning towards sustainable and green chemistry practices. We are committed to reducing solvent use, recycling materials, and utilizing bio-based feedstocks, aligning with global trends for a more environmentally friendly approach to pharmaceutical manufacturing.

Leveraging New Technologies: A Competitive Edge

State-of-the-Art Facilities

Actelion Pharmaceuticals Deutschland GmbH stays ahead in the competitive landscape by embracing innovations in technology. Our Livron and Leipzig facilities boast state-of-the-art, automated filling lines for sterile and non-sterile liquids. These advanced lines enhance production efficiency and ensure a high level of precision, enabling us to maintain our high-quality standards.

Digitalization and Automation

The integration of digital tools and automation is central to our operations. By leveraging advanced analytics and real-time data, we can continuously improve customer interaction and operational efficiency. This digital transformation not only streamlines our processes but also contributes to higher customer satisfaction.

Future Priorities: Technology and Market Expansion

Technological Infrastructure

Over the next five years, Actelion Pharmaceuticals Deutschland GmbH aims to enhance its technological infrastructure further. We are exploring possibilities with AI tools for automating manual processes, which will contribute to greater efficiency and flexibility. Our focus on digitalization will ensure we remain at the forefront of the pharmaceutical industry.

Market Expansion

We plan to strengthen our presence in Europe, Japan, and North America. This expansion will allow us to meet the growing demand for specialized CDMO services and maintain our competitive edge in the market.

Why Choose Actelion Pharmaceuticals Deutschland GmbH?

Expertise in the Process Industries

As a participant in the process industries, Actelion Pharmaceuticals Deutschland GmbH offers unparalleled expertise in chemical processes and pharmaceutical manufacturing. Our comprehensive services, from development to commercialization, make us a one-stop solution for all your pharmaceutical needs.

Commitment to Sustainability

Our commitment to sustainability and green chemistry sets us apart from other CDMOs. We believe in responsible manufacturing practices that minimize waste and environmental impact, aligning with global efforts towards climate neutrality.

Cutting-Edge Innovations

Our investments in innovations and state-of-the-art technologies ensure that we offer the most advanced solutions in the market. Whether it’s automated filling lines or real-time data analytics, we are at the cutting edge of the pharmaceutical industry.

As we approach Achema 2024, Actelion Pharmaceuticals Deutschland GmbH stands ready to showcase its innovative solutions and technologies. With a focus on rare diseases, a commitment to supply chain resilience, and a dedication to sustainability, we offer a unique value proposition for pharmaceutical companies looking for a reliable and forward-thinking partner. We invite you to visit our booth at Achema Frankfurt and explore the endless possibilities we offer.

FAQs about Achema